Issues: Vax Specific

Anthrax

Hepatitis B

Hib

HPV

Influenza

Lyme Disease
Meningococcal

MMR    

Polio

Rotavirus

● Smallpox

Tdap/Td

Varicella

Yellow Fever

 

Issues: Misc

Exemptions

Legislation 

New Vax Status

Thimerosal

Independent Vax  Safety Board

 

Vaccine Info

2009 Schedule

ACIP Recs

Components
IOM Reports

● Vax Injury Comp Program
Manufacturer Links

Package Inserts

Reporting AEs

Thimerosal Table

VAERS

VISs

 

Links
 

Search
 

About IVS

Faculty Biographies

Publications

Donations

 

Email IVS

 

Disclaimers & Privacy
 

 

Institute for Vaccine Safety

Johns Hopkins Bloomberg School of Public Health

615 N. Wolfe Street

Room W5041

Baltimore, MD 21205

www.vaccinesafety.edu

 
 
 

www.myflushot.org

 

Real Time Immunization Monitoring System (RTIMS)

Information for
Influenza Vaccine Recipients

IVS-RTIMS home

Thank you for your interest in sharing your flu vaccine experience; the information you provide will
help us monitor influenza vaccine safety across the United States.
 

With support from the CDC, we have created an automated internet-based system that will follow-up 
on any self-reported adverse symptoms to influenza vaccine after vaccination.

What is this project about?

As you may know, health authorities are expecting more than half the American population to receive their H1N1 (swine) flu vaccination in just a few months.  The H1N1 vaccine is made exactly the same way as seasonal flu, and adverse events are expected to be very rare.  The U.S. Centers for Disease Control and Prevention (CDC) has launched an effort to ensure the safety of the H1N1 vaccine nationwide. (more information about this effort)
 
Our project aims to enhance existing monitoring of vaccine safety across the United States.  We have created an automated web-based system that will ask you how you have been feeling after your H1N1 vaccination over the course of several weeks.

Does this mean there’s something wrong with the vaccine?

No.  The H1N1 pandemic flu vaccine is made exactly the same way as seasonal flu vaccine, which is used every year with an excellent safety record.   The new H1N1 vaccine has also received more scientific scrutiny than seasonal flu vaccines do – several thousand people in studies to determine the right dose of H1N1 vaccine have not reported any unusual symptoms. 
 
The CDC is planning to watch more closely than ever for any adverse events among those who get the new vaccine.  Our study is part of this surveillance to ensure that the H1N1 vaccine continues to meet the highest possible safety standards.

What will I have to do?

If you agree to participate at www.myflushot.org, you will be asked to complete an online survey that asks a series of questions including demographic information, influenza vaccine history, type of influenza vaccine received, and any medical problems you may have developed since vaccination.
 
The initial survey will take 3 to 4 minutes to complete, with two short follow-up online surveys at 1 week and 6 weeks after vaccination.

Is there any compensation for me?

Unfortunately, no.  However, your responses will help us in ensuring that this year’s seasonal and H1N1 influenza vaccines remain safe and effective.

How long will this take?

The online questionnaire will only take 3 to 4 minutes.

Will I receive unwanted calls?

No.  You will only be called if you have given us permission to contact you.  Your personal information will not be disclosed to anyone.

How do I get started?

Click the button below to access the survey.

www.myflushot.org

 

IVS-RTIMS home 

This page was last updated on October 15, 2009

© 2009 Institute for Vaccine Safety